Foto van J. H. Gerrits (Jeroen)

J. H. Gerrits (Jeroen)

Klinisch chemicus

Werkzaam bij het Ommelander Ziekenhuis sinds

2013

Specialisaties

Allergie, auto-immuniteit en kwaliteit (erkend auditor Raad voor Accreditatie)

Opleidingen en werkervaring

2013 Registratie Klinisch Chemicus
2009 – 2013 Klinisch Chemicus in opleiding, bij Martini Ziekenhuis, LabNoord
2003-2010 Proefschrift ‘Donor-reactive T-cell responses after HLA-identical living-related kidney transplantation’, bij Erasmus MC, Interne Geneeskunde – Transplantatie, Rotterdam
2000 – 2003 Biologie, bij Katholieke Universiteit Nijmegen

Wetenschappelijke publicaties

Eerste auteur:


  • Granzyme B Elispot assay determines the cytotoxic T-lymphocyte precursor frequency after HLA-identical living-related kidney transplantation. (Transplant Proc 2005;37(2):752-754; impact factor:1)
  • Donor-reactive cytokine production after HLA-identical living-related kidney transplantation: a protein-array. (Transplant Proc 2006; 38(9): 2825-2827; impact factor:1)
  • Peripheral blood manipulation significantly affects the result of dendritic cell monitoring. (Transplant Immunol 2007;17(3):169-177; impact factor: 2,1) 
  • Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living related kidney transplant recipients despite minor histocompatibility antigen mismatches. (Nephrol Dial Transplant 2007;22;353-361; impact factor: 3,2)
  • Immune monitoring after kidney transplantation. (Minerva Urol Nefrol 2007;59:376-372; impact factor: onbekend)
  • Donor-reactive cytokine-profiles after HLA-identical living-related kidney transplantation. (Nephrol Dial Transplant 2007;22:353-361; impact factor: 3,2) 
  • T-cell reactivity during tapering of immunosuppression to low dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients. (Transplantation 2009; 87:907-914; impact factor: 3,5) 
  • A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living-related kidney transplant patients. (Transplant Proc 2009; 41(5): 1577-1582; impact factor: 1)
  • Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation. (Clin Transplant 2009; 23(5): 740-747; impact factor: 2,0)
  • Polymorphic mononuclear neutrophils CD64 index for diagnosis of sepsis in postoperative surgical patients and critically ill patients. (Clin Chem Lab Med 2012; 0(0): 1-9; impact factor: 2,2) 

Mede-auteur:

  •  Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantation. (Transplantation 2009; 87(5):740-744; impact factor: 3,5) 
  • Migration of allosensitizing donor myeloid dendritic cells into recipients after liver transplantation. (Liver Transplant 2010;16(1): 12-22; impact factor: 3,1)